Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Number 12—December 2025

Synopsis

Retrospective Multicenter Study of Human Granulocytic Anaplasmosis, France, 2012–2024

Victor GerberComments to Author , Thomas Lemmet, Thomas Bonijoly, Baptiste Hoellinger, Anne Pachart, Amandine Woerly, Dominique De Briel, Emilie Talagrand-Reboul, Martin Martinot, Pierre Boyer, and Yves Hansmann
Author affiliation: Centre Hospitalier Universitaire de Strasbourg, Strasbourg, France (V. Gerber, T. Lemmet, B. Hoellinger, A. Woerly, E. Talagrand-Reboul, P. Boyer, Y. Hansmann); Hôpitaux Civils de Colmar, Colmar, France (V. Gerber, T. Lemmet, A. Pachart, D. De Briel, M. Martinot); Centre National de Référence des Borrelia, Strasbourg (V. Gerber, E. Talagrand-Reboul, P. Boyer, Y. Hansmann); Université de Strasbourg, Strasbourg (V. Gerber, E. Talagrand-Reboul, P. Boyer, Y. Hansmann); Centre Hospitalier de Sélestat, Sélestat, France (T. Bonijoly); Groupe Hospitalier de la Région de Mulhouse Sud-Alsace, Mulhouse, France (B. Hoellinger)

Main Article

Table 1

Characteristics and underlying conditions among 38 patients in a retrospective multicenter study of human granulocytic anaplasmosis, France, 2012–2024*

Patient characteristics Value
Mean age, y (range)
 60.2 (34–87)
Sex
F 14 (36.8)
M
 24 (63.2)
Participated in outdoor activities 16 (42.1)
Lived in a rural area
 29 (76.3)
Underlying conditions
High blood pressure 13 (34.2)
Tobacco use 4 (10.5)
Immunosuppression 4 (10.5)
Diabetes mellitus 2 (5.3)
Chronic kidney disease, GFR <60 mL/min 1 (2.6)
Chronic respiratory disease 1 (2.6)
Chronic cardiac failure, LVEF <45% 1 (2.6)

*Values are no. (%) except as indicated. One patient had 2 distinct Anaplasma spp. infections occurring 11 months apart. GFR, glomerular filtration rate; LVEF, left ventricular ejection fraction.

Main Article

Page created: December 04, 2025
Page updated: December 15, 2025
Page reviewed: December 15, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external